CAPTRUST Financial Advisors
ORTX

CAPTRUST Financial Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-75
Closed – – 4348
2022
Q2 		$0 Hold
75
– – ﹤0.01% 5213
2022
Q1 		$1K Buy
+75
New +$735 ﹤0.01% 4786

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CAPTRUST Financial Advisors's ORTX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 75 shares.

CAPTRUST Financial Advisors first reported a position in ORTX in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 75 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $1K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.